Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Significance of hepatitis C virus baseline polymorphism during the antiviral therapy].

Orvosi hetilap - 24 May 2015

Tornai István

Abstract excerpt

The treatment of chronic hepatitis C has developed significantly during the last 25 years. In patients with genotype 1 infection 40-50% sustained virologic response could be achieved using pegylated interferon and ribavirin dual combination, which could be increased significantly with the introduction of direct acting antivirals. Three major groups of direct acting antivirals are known, which directly inhibit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclopropanes
Share to Heterocyclic Compounds, 3-Ring
Share to Lactams, Macrocyclic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Macrocyclic Compounds

Share to Nucleic Acid Synthesis Inhibitors

Share to Oligopeptides

Share to Protease Inhibitors

Share to Simeprevir

Source

Identifiers

PMID: 26038992
DOI: 10.1556/650.2015.30180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Significance of hepatitis C virus baseline polymorphism during the antiviral therapy].PMID 26038992Read ↗

[The value of genetics in the era of hepatitis C triple therapy].Semantic proximity Read ↗

[Clinical significance of drug resistance-associated mutations in treatment of hepatitis C with direct-acting antiviral agents].Semantic proximity Read ↗

[Hepatitis B and C virus antiviral resistance].Semantic proximity Read ↗

Directly acting antivirals against hepatitis C virus: mechanisms of action and impact of resistant associated variants.Semantic proximity Read ↗

Analysis of Naturally Occurring Resistance-Associated Variants to NS3/4A Protein Inhibitors, NS5A Protein Inhibitors, and NS5B Polymerase Inhibitors in Patients With Chronic Hepatitis C.Semantic proximity Read ↗

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.Semantic proximity Read ↗

[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].Semantic proximity Read ↗

Hepatitis C virus resistance to the new direct-acting antiviralsSemantic proximity Read ↗

Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals.Semantic proximity Read ↗

Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Semantic proximity Read ↗

Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.Semantic proximity Read ↗

Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.